Drug Shortage Report for TEVA-FUROSEMIDE
| Report ID | 218940 |
| Drug Identification Number | 00337749 |
| Brand name | TEVA-FUROSEMIDE |
| Common or Proper name | FUROSEMIDE 40MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | FUROSEMIDE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100's |
| ATC code | C03CA |
| ATC description | HIGH-CEILING DIURETICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-07 |
| Estimated end date | 2025-02-10 |
| Actual end date | 2025-01-29 |
| Shortage status | Resolved |
| Updated date | 2025-01-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v23 | 2024-10-11 | French | Compare |
| v22 | 2024-10-11 | English | Compare |
| v21 | 2024-10-11 | English | Compare |
| v20 | 2024-09-23 | French | Compare |
| v19 | 2024-09-23 | English | Compare |
| v18 | 2024-09-19 | French | Compare |
| v17 | 2024-09-19 | English | Compare |
| v16 | 2024-09-12 | French | Compare |
| v15 | 2024-09-12 | English | Compare |
| v14 | 2024-09-05 | French | Compare |
| v13 | 2024-09-05 | English | Compare |
| v12 | 2024-08-30 | French | Compare |
| v11 | 2024-08-30 | English | Compare |
| v10 | 2024-08-01 | French | Compare |
| v9 | 2024-08-01 | English | Compare |
| v8 | 2024-07-04 | French | Compare |
| v7 | 2024-07-04 | English | Compare |
| v6 | 2024-06-27 | French | Compare |
| v5 | 2024-06-27 | English | Compare |
| v4 | 2024-02-15 | French | Compare |